These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1989951)

  • 21. Multiple myeloma among atomic bomb survivors in Hiroshima and Nagasaki, 1950-76: relationship to radiation dose absorbed by marrow.
    Ichimaru M; Ishimaru T; Mikami M; Matsunaga M
    J Natl Cancer Inst; 1982 Aug; 69(2):323-8. PubMed ID: 6955540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk.
    Land CE; Saku T; Hayashi Y; Takahara O; Matsuura H; Tokuoka S; Tokunaga M; Mabuchi K
    Radiat Res; 1996 Jul; 146(1):28-36. PubMed ID: 8677295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal analysis of a dose-response relationship: leukemia mortality in atomic bomb survivors.
    Brodsky JB; Groer PG; Liddell R; Ishimaru T; Ichimaru M
    Radiat Res; 1984 Sep; 99(3):547-61. PubMed ID: 6473713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M; Schull WJ
    Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The RBE of low-LET radiations.
    Chadwick KH; Leenhouts HP
    J Radiol Prot; 2009 Sep; 29(3):445-47; author reply 447-9. PubMed ID: 19696460
    [No Abstract]   [Full Text] [Related]  

  • 26. More about cancer incidence in atomic bomb survivors: solid tumors, 1958-1987.
    Ron E; Preston DL; Mabuchi K
    Radiat Res; 1995 Jan; 141(1):126-7. PubMed ID: 7997509
    [No Abstract]   [Full Text] [Related]  

  • 27. Review of relative biological effectiveness dependence on linear energy transfer for low-LET radiations.
    Hunter N; Muirhead CR
    J Radiol Prot; 2009 Mar; 29(1):5-21. PubMed ID: 19225189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship of gamma and neutron radiation to posterior lenticular opacities among atomic bomb survivors in Hiroshima and Nagasaki.
    Otake M; Schull WJ
    Radiat Res; 1982 Dec; 92(3):574-95. PubMed ID: 7178422
    [No Abstract]   [Full Text] [Related]  

  • 29. Comments on the paper: Microsatellite instability in acute myelocytic leukaemia developed from A-bomb survivors.
    Little MP
    Int J Radiat Biol; 2002 May; 78(5):441-3. PubMed ID: 12020434
    [No Abstract]   [Full Text] [Related]  

  • 30. Mortality study of atomic-bomb survivors: implications for assessment of radiation accidents.
    Shimizu Y; Mabuchi K; Preston DL; Shigematsu I
    World Health Stat Q; 1996; 49(1):35-9. PubMed ID: 8896256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of the mortality of A-bomb survivors, report 7. Part III. incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki.
    Wakabayashi T; Kato H; Ikeda T; Schull WJ
    Radiat Res; 1983 Jan; 93(1):112-46. PubMed ID: 6823504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data.
    Pierce DA; Stram DO; Vaeth M
    Radiat Res; 1990 Sep; 123(3):275-84. PubMed ID: 2217725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some effects of random dose measurement errors on analyses of atomic bomb survivor data.
    Gilbert ES
    Radiat Res; 1984 Jun; 98(3):591-605. PubMed ID: 6729054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis associated antigen and antibody in A-bomb survivors and nonexposed subjects in Hiroshima and Nagasaki.
    Belsky JL; Okochi K; Ishimaru T; Hamilton HB
    Radiat Res; 1972 Dec; 52(3):528-35. PubMed ID: 4539561
    [No Abstract]   [Full Text] [Related]  

  • 35. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis.
    Little MP; Weiss HA; Boice JD; Darby SC; Day NE; Muirhead CR
    Radiat Res; 1999 Sep; 152(3):280-92. PubMed ID: 10453089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dose-dependent decrease in the fraction of cases harboring M6P/IGF2R mutations in hepatocellular carcinomas from the atomic bomb survivors.
    Iwamoto KS; Yano S; Barber CL; MacPhee DG; Tokuoka S
    Radiat Res; 2006 Dec; 166(6):870-6. PubMed ID: 17149973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of somatic cell mutations at the glycophorin A locus in atomic bomb survivors: a comparative study of assay methods.
    Langlois RG; Akiyama M; Kusunoki Y; DuPont BR; Moore DH; Bigbee WL; Grant SG; Jensen RH
    Radiat Res; 1993 Oct; 136(1):111-7. PubMed ID: 8210326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to 'Supra-linear dose-response in the A-bomb study'.
    Izatt JA
    Health Phys; 1991 Feb; 60(2):281. PubMed ID: 1989951
    [No Abstract]   [Full Text] [Related]  

  • 39. Supra-linear dose-response in the A-bomb study.
    Gofman JW
    Health Phys; 1989 Dec; 57(6):1037-8. PubMed ID: 2584021
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancer dose-response in A-bomb survivors: erroneous basis of Izatt's 'fairly conclusive evidence' for hormesis.
    Gofman JW
    Health Phys; 1991 Feb; 60(2):281-2. PubMed ID: 1989952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.